© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 0738T refers to the treatment planning process for magnetic field induction ablation of malignant prostate tissue. This innovative technique utilizes data obtained from a previously conducted magnetic resonance imaging (MRI) examination to effectively target and treat tumors within the prostate. The procedure involves the injection of a specialized suspension containing magnetic nanoparticles directly into the areas of prostate tissue that are identified as targets for ablation. Following the injection, the patient is exposed to an alternating magnetic field, which is carefully controlled to generate heat and ablate the malignant tissue. A critical aspect of this procedure is the meticulous planning required to ensure accurate targeting of the tumor. This includes determining the precise locations for the injection of nanoparticles, calculating the appropriate volume of nanoparticles for each targeted area, and strategically placing temperature sensors to monitor the tissue temperatures during the ablation process. The physician relies on the detailed imaging provided by the MRI to create a comprehensive map of the prostate, which guides the entire treatment planning phase and enhances the effectiveness of the ablation procedure.
© Copyright 2025 Coding Ahead. All rights reserved.
The treatment planning for magnetic field induction ablation of malignant prostate tissue is indicated for patients diagnosed with prostate cancer, particularly when traditional treatment options may not be suitable or effective. The procedure is specifically designed for cases where precise targeting of malignant tissue is essential to minimize damage to surrounding healthy tissue. The use of MRI data is crucial in identifying the tumor's location and characteristics, ensuring that the treatment is tailored to the individual patient's needs.
The procedure for treatment planning involves several critical steps to ensure the effective ablation of malignant prostate tissue. Each step is designed to maximize the precision and safety of the treatment.
After the treatment planning phase is completed, the next steps involve preparing for the actual ablation procedure. While specific post-procedure care details are not provided in the CPT® data, it is generally expected that the physician will monitor the patient for any immediate reactions to the treatment. Follow-up appointments may be scheduled to assess the effectiveness of the ablation and to monitor for any potential complications. Additionally, the physician may provide instructions regarding activity restrictions and signs of complications that the patient should be aware of following the procedure.
Short Descr | TX PLN MAG FLD ABLTJ PRST8 | Medium Descr | TX PLANNING MAG FLD INDCTJ ABLTJ MAL PRST8 TISS | Long Descr | Treatment planning for magnetic field induction ablation of malignant prostate tissue, using data from previously performed magnetic resonance imaging (MRI) examination | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
Date
|
Action
|
Notes
|
---|---|---|
2023-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.